Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin

Inclusion Criteria: * Healthy male and female (not of childbearing potential) participants as determined by medical and surgical history and assessments * Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive * Normal kidney function at screening Exclusion Criteria: * History of chronic headaches (eg, migraines, cluster headaches), defined as occurring 15 days or more a month, over the previous 3 months * History of headaches related to caffeine withdrawal, including energy drinks * History of syncope, orthostatic instability, or recurrent dizziness Other protocol defined inclusion and exclusion criteria could apply